Delivery Order SPE2DB22D3010-SPE2DB24FP3AY

Award Date 8/14/24
Potential Completion Date 8/15/24
Potential Value $5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $44,053.02, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order for the supply of Varenicline 1 mg Tablets in 56-count packages. The contract has an ultimate completion date of October 6, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Varenicline 1 mg tablets. The contract, valued at $1,014.75, is a firm fixed-price delivery order with a completion date of February 12, 2025. Amerisourcebergen, a for-profit organization, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Varenicline 1 mg tablets. The contract, valued at $1,806.76, is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, which is valued at $999,999,999 and runs through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Varenicline 1 mg tablets. The contract, valued at $3,811.90, is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to supply a wide range of...
This federal contract award is for the delivery of 4,558,471,872 units of Varenicline 0.5 mg tablets in 56-count packages. The contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on September 15, 2022. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $30,753.61 and an ultimate completion date of September 16, 2022. The contract is not set aside for any specific business type. AmerisourceBergen...
This federal contract award, valued at $1,713.03, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of Varenicline 0.5 mg tablets, a prescription medication, to support Department of Defense (DoD) and other government healthcare programs. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop...
This federal contract award, valued at $4,277.55, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the provision of 4,557,931,791 varenicline 1 mg tablets. Amerisourcebergen, a major pharmaceutical distributor, is the prime contractor on this firm fixed-price delivery order contract, which does not have a set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $1,064.44 firm fixed-price delivery order is for the supply of 4567833512 - Varenicline 0.5 mg Tablet 56s. The contract has an ultimate completion date of April 9, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award by the Defense Logistics Agency (DLA) is for the delivery of 56 tablets of the pharmaceutical product Varenicline 1 mg. The contract, valued at $10,083.01, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm-Fixed-Price Delivery Order with an ultimate completion date of April 30, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a major pharmaceutical distributor, a delivery order contract valued at $1,673.82 for the supply of 4,565,031,699 units of the drug varenicline 1 mg tablets. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this single-award IDC, Amerisourcebergen provides a wide range of pharmaceutical...
  • SPE2DB22D3010
    Indefinite Delivery Contract
  • SPE2DB22D3010-SPE2DB24FP3AY
    Delivery Order

This federal contract award, valued at $5,048.21, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4565451278 - Varenicline 0.5 mg tablets in 56-count packages.

The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure a wide range of pharmaceutical and medical supplies from Amerisourcebergen to support military treatment programs and facilities worldwide.

The contract does not have a set-aside designation and is scheduled for completion by August 15, 2024. As a large pharmaceutical distributor, Amerisourcebergen leverages its extensive supply chain to provide critical medications and medical commodities to various government agencies and healthcare programs.

Generated 11/13/24, 9:25 AM